Moderna
MRNA
#1676
Rank
โ‚ฌ8.43 B
Marketcap
21,82ย โ‚ฌ
Share price
1.68%
Change (1 day)
-77.72%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -8,60ย โ‚ฌ

According to Moderna 's latest financial reports the company's current EPS (TTM) is -7,94ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 18,34ย โ‚ฌ a decrease over its 2021 EPS that were of 26,29ย โ‚ฌ.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-8,60ย โ‚ฌ-146.89%
202218,34ย โ‚ฌ-30.25%
202126,29ย โ‚ฌ-1660.82%
2020-1,68ย โ‚ฌ25.16%
2019-1,35ย โ‚ฌ37.04%
2018-0,98ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,47ย โ‚ฌ-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
1,58ย โ‚ฌ-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,63ย โ‚ฌ-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-3,57ย โ‚ฌ-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
3,25ย โ‚ฌ-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-1,48ย โ‚ฌ-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
12,23ย โ‚ฌ-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA